Public Profile

Auro Medics Pharma Llc

Auro Medics Pharma LLC, headquartered in the United States, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality generic medications. Founded in 2006, the company has established a strong presence in key operational regions, including North America and beyond, focusing on delivering affordable healthcare solutions. Auro Medics Pharma is renowned for its extensive portfolio of products, which includes a wide range of oral solid dosage forms and injectables. The company’s commitment to quality and innovation sets it apart, ensuring that its offerings meet rigorous regulatory standards. With a reputation for reliability and excellence, Auro Medics has achieved significant milestones, positioning itself as a trusted partner in the healthcare sector.

DitchCarbon Score

How does Auro Medics Pharma Llc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

27

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Auro Medics Pharma Llc's score of 27 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Auro Medics Pharma Llc's reported carbon emissions

Auro Medics Pharma LLC, headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or climate commitments outlined in their initiatives. Without concrete figures or commitments, it is challenging to assess their carbon footprint or climate strategy. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing greenhouse gas emissions, indicating a broader trend towards environmental responsibility. Auro Medics Pharma may be aligning with these industry standards, but specific details on their emissions or climate actions remain unspecified.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Auro Medics Pharma Llc's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Auro Medics Pharma Llc is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Auro Medics Pharma Llc is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Fresenius Kabi USA, LLC

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Hospira

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Meitheal Pharmaceuticals, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

American Regent, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Perrigo

IE
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Teva Pharmaceuticals

IL
Pharmaceutical Preparation Manufacturing
Updated about 5 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers